Indefinite Delivery Contract 36C24422D0015
- Not listed
- The Department of Veterans Affairs (VA) Veterans Integrated Service Network 1 (VISN 1) has awarded a 5-year Blanket Purchase Agreement (BPA) to Roche Diagnostics Corporation for the provision of Point-of-Care (POC) Coagulation Testing services. The contract, valued at up to $234,500, will cover the supply of Roche's coagulation testing meters, associated supplies, reagents, network connections, service, maintenance, and parts required to produce patient test results. This sole-source procurement...
- The Department of Veterans Affairs Veterans Integrated Service Network 2 awarded a Blanket Purchase Agreement to Roche Diagnostics Corporation for the supply of coagulation test strips, controls, reagent and assay reagent labeling system (RALS) modules, and associated device charges. This single-award, non-set-aside contract has a ceiling value of $139,514.30 and is effective through November 30, 2025, with an award date of December 1, 2024. The solicitation was issued as a sole-source...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 awarded an indefinite-delivery contract to Roche Diagnostics Corporation to provide reagents, consumables, chemicals, and laboratory testing materials. Over the past four years, multiple delivery orders have been placed against this contract vehicle valued at $124,700.93 to $317,191.19 with periods of performance ranging from December 2020 through November 2024. Places of performance for...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded an indefinite delivery contract to Roche Diagnostics Corporation to provide laboratory testing supplies and equipment. The IDV has a potential value of $6.5 million and period of performance through June 2027. Three delivery orders have been issued against the contract to date for a total of $246,135.04, $231,704.12, and $13,824 for reagents, supplies, and molecular testing systems...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 awarded a single award indefinite delivery contract to Roche Diagnostics Corporation with a potential value of $732,474.12 to provide testing supplies. Under this contract vehicle, two firm fixed price delivery orders have been issued to date. The first delivery order, valued at $82,852.16, requires Roche to supply testing materials to the Sioux Falls Health Care System from November 2023...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 awarded Roche Diagnostics Corporation an indefinite delivery contract for reagents. The IDV has a potential value of $700,000 and a period of performance through September 1, 2027. No set-aside was used. Under the IDV, Roche Diagnostics has received multiple delivery orders for reagents to support medical testing programs across VISN 1 facilities. Delivery orders ranged in value from...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 9 awarded Roche Diagnostics Corporation a single award indefinite delivery contract with a potential value of $204,616 to provide CoaguChek and Accu-Chek supplies. The base period of performance is from October 1, 2020 through September 30, 2024 with three optional years for ordering. No set-aside provisions were applied. Under the contract, Roche Diagnostics has been issued four firm fixed...
- The Department of Veterans Affairs (VA), through its Veterans Integrated Service Network 19 (VISN 19), has awarded a series of Blanket Purchase Agreement (BPA) call orders to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, and laboratory instruments. These contract awards, valued at over $11 million collectively, provide VISN 19 with comprehensive chemistry and immunochemistry laboratory services, including testing equipment, reagents, and...
- The Department of Veterans Affairs (VA) Veterans Integrated Service Network 6 has awarded a single-award Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics, reagents, and related laboratory equipment and supplies. The IDC, valued at up to $3,272,813.29, has a period of performance through September 30, 2025 and allows the agency to issue delivery orders for Roche's products and services on an as-needed basis. Under this IDC, the VA has...
- The Department of Veterans Affairs (VA) Veterans Integrated Service Network 1 (VISN 1) has awarded a Blanket Purchase Agreement (BPA) contract valued at $5,223,493.58 to Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics, reagents, and laboratory equipment. Under this multiple award IDV, Roche will provide VENTANA histology reagents and supplies to support laboratory operations at VA medical centers in the VISN 1 network covering the northeastern U.S. The...
- 36C24422D0015Indefinite Delivery Contract
- 16Federal Contract Awards
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 4 awarded an indefinite delivery contract to Roche Diagnostics Corporation to provide coagulation testing, supplies, and equipment. The IDV has a potential value of $864,800 and a period of performance through January 31, 2027. Against this vehicle, eight firm fixed price delivery orders have been placed with Roche Diagnostics Corporation for various coagulation testing, testing supplies, and laboratory services. The orders range in value from approximately $13,000 to $52,000 and involve places of performance in Pennsylvania, Ohio, Delaware, and Lebanon, Pennsylvania where Roche Diagnostics Corporation is headquartered. The delivery orders were awarded between June 2022 and March 2023 to support the healthcare programs administered by VISN 4, which oversees VA medical centers in Pennsylvania and Ohio. The purpose of the IDV and subsequent delivery orders is to facilitate blood coagulation testing for veterans served by VISN 4. Coagulation testing, also known as clotting testing, evaluates a patient's ability to form blood clots and manage bleeding disorders. By providing the specialized testing, supplies, and laboratory services awarded to Roche Diagnostics Corporation, the VA aims to assist veterans in the region with accessing quality healthcare services related to blood clotting abilities. No set-aside provisions were applied to the IDV or delivery order awards.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 11/19/21 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order 36C24422D0015-36C24424N0462 | Roche Diagnostics Corporation | $13.3k | 6/1/24 | 5/31/25 | 5/14/24 | |
Delivery Order 36C24422D0015-36C24426N0251 | Roche Diagnostics Corporation | $23.7k | 2/1/26 | 1/31/27 | 12/16/25 | |
Delivery Order 36C24422D0015-36C24422N0271 | Roche Diagnostics Corporation | $32.8k | 3/25/22 | 3/24/23 | 7/17/23 | |
Delivery Order 36C24422D0015-36C24425N0243 | Roche Diagnostics Corporation | $23.7k | 2/1/25 | 1/31/26 | 2/11/25 | |
Delivery Order 36C24422D0015-36C24425N0274 | Roche Diagnostics Corporation | $27.2k | 2/1/25 | 3/24/26 | 3/5/25 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
6550--5 Year IDIQ - Coagulation Testing for New Contract Feb 1, 2022-Jan 31, 2027. | 36C24422Q0051 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 4 | Limited / Sole Source Justification 1/1 | 11/19/21, 12:49 PM |